Jiri J. Frohlich
#149,919
Most Influential Person Now
Jiri J. Frohlich's AcademicInfluence.com Rankings
Jiri J. Frohlichphilosophy Degrees
Philosophy
#8248
World Rank
#11590
Historical Rank
Logic
#5282
World Rank
#6669
Historical Rank

Download Badge
Philosophy
Jiri J. Frohlich's Degrees
- Doctorate Medicine University of Zurich
- PhD Cardiology University of Zurich
Why Is Jiri J. Frohlich Influential?
(Suggest an Edit or Addition)Jiri J. Frohlich's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
- Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency (1999) (1742)
- Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. (2001) (1629)
- The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). (2001) (935)
- 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. (2009) (789)
- Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. (2003) (509)
- Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). (2007) (509)
- Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment (2003) (486)
- Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel (2006) (478)
- The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. (1997) (372)
- Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. (2003) (362)
- The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. (2003) (340)
- Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. (2006) (336)
- Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. (2000) (329)
- Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. (2003) (288)
- Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. (1999) (280)
- Homozygous Tangier disease and cardiovascular disease. (1994) (251)
- Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. (2000) (226)
- Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action. (1999) (192)
- Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (2011) (189)
- Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. (2011) (186)
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016). (2016) (186)
- Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference. (2011) (181)
- Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography (2011) (177)
- Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. (1991) (171)
- Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update. (2013) (169)
- Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E‐related disorders in humans (2001) (151)
- "Tall oil"-derived phytosterols reduce atherosclerosis in ApoE-deficient mice. (1997) (142)
- Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. (1998) (138)
- Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. (1999) (137)
- Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. (2010) (132)
- Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. (1994) (132)
- Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). (2004) (124)
- Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study (2011) (123)
- Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. (2002) (121)
- High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. (1994) (121)
- DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias. (1987) (118)
- Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. (2003) (113)
- Advances in Experimental Dyslipidemia and Atherosclerosis (2001) (110)
- Glomerular disease in hypercholesterolemic guinea pigs: a pathogenetic study. (1988) (109)
- Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background. (1997) (107)
- Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. (2003) (107)
- Visceral Adipose Tissue, a Potential Risk Factor for Carotid Atherosclerosis: Results of the Multicultural Community Health Assessment Trial (M-CHAT) (2007) (105)
- The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial. (2003) (98)
- The effects of age, smoking, and alcohol on routine laboratory tests. (1981) (95)
- The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial. (2006) (92)
- Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia. (2019) (92)
- Canadian Cardiovascular Society position statement on familial hypercholesterolemia. (2014) (91)
- APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. (2004) (89)
- The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. (2003) (89)
- Vascular Calcifications in Homozygote Familial Hypercholesterolemia (2008) (87)
- Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. (1993) (86)
- Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease. (1991) (84)
- Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up. (2004) (81)
- Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency. (1988) (81)
- The relationship between waist circumference and metabolic risk factors: cohorts of European and Chinese descent. (2002) (79)
- Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene. (1995) (76)
- The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort. (2012) (76)
- Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. (1992) (76)
- Intraobserver and interobserver reliability of waist circumference and the waist-to-hip ratio. (2001) (74)
- Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects. (2002) (73)
- A review on lecithin:cholesterol acyltransferase deficiency. (2015) (73)
- Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels. (2000) (73)
- Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High‐Dose Simvastatin (2007) (69)
- Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia. (2005) (69)
- Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor. (2001) (66)
- Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort (2006) (65)
- Hypertriglyceridemic hyperapoB in type 2 diabetes. (2002) (65)
- Dietary sitostanol reduces plaque formation but not lecithin cholesterol acyl transferase activity in rabbits. (1998) (64)
- Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene. (1993) (64)
- Implementing phytosterols into medical practice as a cholesterol-lowering strategy: overview of efficacy, effectiveness, and safety. (2014) (63)
- The impact of dietary changes and dietary supplements on lipid profile. (2011) (62)
- Phenotypic heterogeneity of sitosterolemia Published, JLR Papers in Press, September 16, 2004. DOI 10.1194/jlr.M400310-JLR200 (2004) (61)
- Cardiovascular risk and atherosclerosis prevention. (2013) (61)
- Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol ratio. (1998) (60)
- Canned Soup Consumption and Urinary Bisphenol A : A Randomized Crossover Trial (2011) (59)
- Detection of early atherosclerosis with B mode carotid ultrasonography: assessment of a new quantitative approach. (1999) (59)
- Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada. (1998) (58)
- Plasma lipoproteins and lecithin:cholesterol acyltransferase distribution in patients on dialysis. (1984) (58)
- Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders? (2002) (57)
- Effects of alcohol on plasma lipoprotein metabolism. (1996) (57)
- Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy. (2001) (56)
- Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. (2011) (56)
- Clinical usefulness of lipid ratios to identify men and women with metabolic syndrome: a cross-sectional study (2014) (55)
- Image in cardiovascular medicine. Aortic xanthomatosis with coronary ostial occlusion in a child homozygous for a nonsense mutation in ABCG8. (2003) (54)
- Lack of regression of atherosclerotic lesions in phytosterol-treated apo E-deficient mice. (1999) (52)
- Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus. (2004) (52)
- Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport. (1999) (51)
- Simplified Canadian Definition for Familial Hypercholesterolemia. (2018) (50)
- Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease. (2004) (48)
- Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia. (1994) (48)
- Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes. (2004) (45)
- The concept of precision extended to the atherogenic index of plasma. (2008) (44)
- Histologic, hematologic, and biochemical characteristics of apo E-deficient mice: effects of dietary cholesterol and phytosterols. (1999) (44)
- Are Cardiovascular Disease and Osteoporosis Directly Linked? (2004) (43)
- Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization. (1995) (43)
- Appropriateness of current thresholds for obesity-related measures among Aboriginal people (2007) (42)
- Laboratory standardization of a large international clinical trial: the DAIS experience. DAIS Project Group. Diabetes Atherosclerosis Intervention Study. (2000) (42)
- The Role of Risk Factors in the Development of Atherosclerosis (2001) (40)
- Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort (2014) (40)
- Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B. (2001) (40)
- Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. (2007) (39)
- [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. (2000) (39)
- Erythrocyte membrane alterations in lecithin:cholesterol acyltransferase deficiency. (1978) (39)
- Asymptomatic hypothyroidism and statin-induced myopathy. (2007) (38)
- Role of plant sterols in cholesterol lowering. (2004) (37)
- Common mutations in the lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in a Chinese Canadian population. (2001) (37)
- Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro. (1995) (37)
- Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism. (2001) (37)
- Niacin: from mechanisms of action to therapeutic uses. (2010) (35)
- Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia. (2020) (35)
- Therapeutic Role (2008) (34)
- Common problems in the management of hypertriglyceridemia. (2002) (34)
- The effect of a dietary portfolio compared to a DASH-type diet on blood pressure. (2015) (33)
- Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment. (2001) (33)
- Recommendations for the Management of Dyslipidemia and the Prevention of Cardiovascular Disease: 200 (2003) (33)
- Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol. (2004) (32)
- Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification. (2003) (32)
- Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency. (1982) (32)
- Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial. (2001) (32)
- Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia. (1994) (32)
- The cornea in familial high density lipoprotein deficiency, tangier disease (1991) (32)
- Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation. (1999) (31)
- Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia. (2008) (30)
- Response of cholesterol synthesis to cholesterol feeding in men with different apolipoprotein E genotypes. (1993) (29)
- Atherogenic lipoprotein profile in families with and without history of early myocardial infarction. (2001) (29)
- Specificity of the commonly used enzymatic assay for plasma cholesterol determination (2002) (29)
- Hypoalphalipoproteinemia resembling fish eye disease. (2009) (29)
- Measurement of fractional esterification rate of cholesterol in plasma depleted of apoprotein B containing lipoprotein: methods and normal values. (1996) (29)
- Lecithin: cholesterol acyl transferase (LCAT). (1982) (29)
- Dietary measures and exercise training contribute to improvement of endothelial function and atherosclerosis even in patients given intensive pharmacologic therapy. (2006) (29)
- Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule (2020) (28)
- Lipoprotein (a), an independent cardiovascular risk marker (2016) (28)
- Relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients. (1989) (27)
- A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data (2002) (27)
- Lipid transfer proteins, hypertriglyceridemia, and reduced high-density lipoprotein cholesterol. (1991) (27)
- Structural and functional assessment of high-density lipoprotein heterogeneity. (1994) (27)
- Fish odour syndrome (2011) (27)
- Monocytes and macrophages in focal glomerulosclerosis in Zucker rats. (1991) (26)
- Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis. (2009) (26)
- Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease). (1988) (26)
- Dietary sitostanol and campestanol: Accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues (2005) (26)
- Familial high‐density‐lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent (1992) (26)
- The clinical significance of serum high density lipoproteins. (1989) (25)
- Dyslipidaemia and coagulation defects of insulin resistance. (2000) (25)
- Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines. (2000) (24)
- Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier Disease. (2014) (24)
- Effect of labeling of plasma lipoproteins with [(3)H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma. (2000) (23)
- Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors. (2018) (23)
- Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: comparison to controls without personal and family history of atherosclerosis. (2001) (23)
- Plant sterols and their role in combined use with statins for lipid lowering. (2005) (22)
- Lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes. (1986) (22)
- Fractional Esterification Rate of HDL Particles in Patients With Type 2 Diabetes: Relation to coronary heart disease risk factors (1998) (22)
- Cholesteryl ester transfer activity in plasma measured by using solid-phase-bound high-density lipoprotein. (1987) (22)
- Association of skin cholesterol content, measured by a noninvasive method, with markers of inflammation and Framingham risk prediction. (2002) (21)
- Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design. (1998) (21)
- Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1. (2017) (21)
- Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study. (2017) (21)
- Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients (2015) (21)
- Detection of heterozygotes for familial lecithin: cholesterol acyltransferase (LCAT) deficiency. (1982) (21)
- Assays of lecithin cholesterol acyltransferase (LCAT). (1998) (20)
- Extensive lifestyle management intervention following cardiac rehabilitation: pilot study. (2001) (20)
- Differential effects of simvastatin and atorvastatin on high‐density lipoprotein cholesterol and apolipoprotein A‐I are consistent across hypercholesterolemic patient subgroups (2003) (19)
- Unusual renal biopsy findings in a patient with familial lecithin:cholesterol acyltransferase deficiency. (1982) (19)
- Targeted next-generation sequencing to diagnose disorders of HDL cholesterol[S] (2015) (19)
- Simvastatin plus niacin protect against atherosclerosis progression and clinical events in coronary artery disease patients with metabolic syndrome (2002) (18)
- Characterization of subspecies of apolipoprotein A-I-containing lipoprotein in homozygotes for familial lecithin:cholesterol acyltransferase deficiency. (1994) (18)
- Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds (2014) (16)
- Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial. (1988) (16)
- A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy. (2014) (16)
- Differences in cardiovascular risks in the aboriginal and non-aboriginal people living in Bella Coola, British Columbia. (2005) (16)
- Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol. (2014) (16)
- Cholesterol and triglyceride fatty acid synthesis in apolipoprotein E2-associated hyperlipidemia. (1992) (16)
- Coronary atherosclerosis in anorexia nervosa. (2003) (16)
- Study of the components of reverse cholesterol transport in lecithin:cholesterol acyltransferase deficiency. (1987) (15)
- Old and new risk factors for atherosclerosis and development of treatment recommendations (2002) (15)
- Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. (1993) (15)
- The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency). (1996) (15)
- Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study (2013) (14)
- Case series of type III hyperlipoproteinemia in children (2011) (14)
- Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease. (1986) (13)
- Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature. (2010) (13)
- Interaction of high density lipoprotein with adipocytes in a new patient with Tangier disease. (1987) (13)
- Statin-Associated Muscle Adverse Events: Update for clinicians. (2016) (13)
- Subclinical atherosclerosis in subjects with family history of premature coronary artery disease. (2008) (13)
- Lecithin:cholesterol acyltransferase deficiency. (1988) (13)
- Chemical precipitation of apolipoprotein B-containing lipoproteins facilitates determination of LDL particle size. (2000) (12)
- Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on sterol absorption in hypercholesterolemic subjects. (1999) (12)
- A muclticenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia (1990) (12)
- Use of metabolic drugs and fish oil in HIV‐positive patients with metabolic complications and associations with dyslipidaemia and treatment targets (2007) (12)
- Relation of cholesterol esterification rate to the plasma distribution of high-density lipoprotein subclasses in normal and hypertensive women. (1995) (12)
- Lipoproteins and homocyst(e)ine as risk factors for atherosclerosis: assessment and treatment. (1995) (12)
- Association between apolipoprotein E phenotype and endogenous cholesterol synthesis as measured by deuterium uptake. (1991) (11)
- Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study (2008) (11)
- Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment. (2005) (11)
- Study of erythrocytes in a hereditary hemolytic syndrome (HHS): comparison with erythrocytes in lecithin:cholesterol acyltransferase (LCAT) deficiency. (2009) (11)
- Ancel Keys and the lipid hypothesis: From early breakthroughs to current management of dyslipidemia (2009) (11)
- Regional and national familial hypercholesterolemia registries: present international application, importance, and needs for Canada. (2013) (11)
- Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol. (2013) (11)
- Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure. (2001) (10)
- Handbook of Lipoprotein Testing, 2nd Edition by (2001) (10)
- Extreme hypertriglyceridemia following intravenous heparin infusion. (2008) (9)
- Statin therapy and the management of acute coronary syndromes. (2003) (9)
- Action of a microbial glycerophospholipid:cholesterol acyltransferase on plasma from normal and LCAT-deficient subjects. (1984) (9)
- Purification of biologically active apolipoproteins by chromatofocussing. (1986) (9)
- The British Columbia Familial Hypercholesterolemia Registry (2013) (8)
- Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects. (2013) (8)
- Dramatic lowering of very high Lp(a) in response to niacin. (2014) (8)
- Poster abstractStructural and functional assessment of HDL heterogeneity (1994) (8)
- Erythrocyte alterations in praseodymium-induced lecithin:cholesterol acyltransferase (LCAT) deficiency in the rat: comparison with familial LCAT deficiency in man. (1981) (8)
- Familial defective apolipoprotein B-100 in hypercholesterolemic Chinese Canadians: identification of a unique haplotype of the apolipoprotein B-100 allele. (1997) (7)
- Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency. (1988) (7)
- Assessment of atherogenic profile of plasma using estimation of cholesterol esterification rate in apolipoprotein B depleted plasma (FERHDL) and Logarithmically transformed ratio of triglyceride/HDL-cholesterol (1999) (7)
- Cholesterol-Lowering Foods and Reduction in Serum Cholesterol Levels—Reply (2011) (7)
- Effect of cyclosporin A on serum lipids in primary biliary cirrhosis patients. (1989) (7)
- Predictors of Metabolic Syndrome in Participants of a Cardiac Rehabilitation Program (2012) (7)
- Statins and bones. (2001) (6)
- Dietary supplementation with fish gelatine modifies nutrient intake and leads to sex-dependent responses in TAG and C-reactive protein levels of insulin-resistant subjects (2012) (6)
- Hepatic lipase deficiency in a Middle-Eastern-Arabic male (2010) (6)
- Efficacy and safety of fluvastatin in hyperlipidaemic patients with non-insulin-dependent diabetes mellitus. (1994) (6)
- Statin resistant dyslipidemia in a patient treated with amiodarone (2011) (6)
- Use of ezetimibe results in more patients reaching lipid targets without side effects (2014) (5)
- Serial measurement of plasma cholesterol and lecithin:cholesterol acyl transferase activity in adults receiving total parenteral nutrition. (1985) (5)
- The analysis by Manuel and colleagues creates controversy with headlines, not data (2005) (5)
- Characterization of subspecies of lipoprotein containing apolipoprotein A-I in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency. (1995) (5)
- Detection of vesicular lipoproteins in lecithin:cholesterol acyltransferase-deficient plasma by 1H-NMR spectroscopy. (1989) (5)
- Liver biochemistry abnormalities in a quaternary care lipid clinic database. (2008) (4)
- Apoprotein A-I and lecithin: cholesterol acyltransferase in a patient with Tangier disease. (1986) (4)
- 2.P.195 Gender differences in prediction of coronary artery disease (CAD) by plasma lipoproteins, LCAT measurements (1997) (3)
- Urinary proteins in a patient with Tangier disease. (1985) (3)
- Follow-up of type III hyperlipoproteinaemia in a child (2001) (3)
- Evidence for impaired cellular cholesterol removal mediated by apo A-I containing lipoproteins in patients with familial lecithin: cholesterol acyltransferase deficiency. (1994) (3)
- Effectiveness of Colestipol Tablets vs Granules in Patients with Moderate to Severe Hypercholesterolaemia (1995) (3)
- Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations. (1988) (3)
- Exercise in a Healthy Heart Program: A Cohort Study (2013) (3)
- Erythrocyte abnormalities in a hypoalphalipoproteinemia syndrome resembling fish eye disease (1988) (3)
- Lack of benefit in treating high homocysteine levels with vitamins (2007) (3)
- Lipids and cardiovascular diseases. (1999) (3)
- Dysbetalipoproteinemia and clomipramine. (2005) (3)
- Safety of statin therapy in patients with mitochondrial diseases. (2013) (3)
- The role of apoproteins in disorders of lipoprotein metabolism. (1989) (3)
- Analysis of familial hypoalphalipoproteinemia syndromes (1992) (3)
- Lecithin:cholesterol acyltransferase activity in plasma of patients with multiple sclerosis. (1983) (2)
- CARDIOVASCULAR RISK ASSESSMENT BY ATHEROGENIC INDEX OF PLASMA [LOG(TG/HDL-C)] (2008) (2)
- Carotid ultrasound, coronary calcium, and dyslipidemia patterns in the MESA (Multi-Ethnic Study of Atherosclerosis) cohort. (2010) (2)
- Coronary artery calcium findings in asymptomatic subjects with family history of premature coronary artery disease (2012) (2)
- High resolution lh nmr spectra of human apolipoprotein C-iii2 using DPC to model the lipoprotein environment (1997) (2)
- Workshop abstractCholesterol esterification in plasma and the risk of coronary artery disease (1994) (1)
- W16-O-004 Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment (2005) (1)
- Gender differences in serum levels of Lp(a) in coronary artery disease patients (2000) (1)
- Abstract PR-04: Blood lipid and lipoprotein levels and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (2010) (1)
- Pharmacology of drugs used to treat smoking cessation and obesity (2008) (1)
- Reaching target lipid levels in patients at high risk of cardiovascular event: the experience of a Canadian tertiary care lipid clinic. (2007) (1)
- THE EXTENSIVE LIFESTYLE MANAGEMENT INTERVENTION (ELMI) TRIAL: PILOT STUDY. (1999) (1)
- Relation of anthropometric parameters to the functional assessment of HDL particle size in three ethnic cohorts. (2006) (1)
- Hereditary high phosphatidylcholine hemolytic anemia: report of a new family and review of the literature. (1990) (1)
- COMPLETE APO AI DEFICIENCY IN A FAMILY FROM IRAQ (2008) (1)
- Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: The reply (2000) (1)
- The Atherosclerosis Reversal Clinic: the way of the future. (2001) (1)
- Abstract 9959: An Intensive Lifestyle Modification Program Reduces the Number of Component Factors in Subjects With Metabolic Syndrome (2012) (1)
- Cholesterol efflux capacity and atherosclerosis. (2011) (1)
- Blood cholesterol is causally related to atherosclerosis. (1994) (1)
- W16-P-046 Reaching target lipid levels in high risk patients: The experience of a Canadian tertiary care lipid clinic (2005) (1)
- Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease (2012) (1)
- Comparative efficacy and safety study of pravastatin and gemfibrozil in patients with primary hypercholesterolemia (1994) (1)
- Paediatric type III dyslipidaemia: a case of vanishing hyperlipidaemia (2012) (1)
- Lipid clinics/cardiovascular risk reduction clinics: current state and future consideration. (2001) (1)
- Abstract 243: Canadian Familial Hypercholesterolemia Registry (2014) (1)
- Hepatic Lipase Deficiency in a Middle-Eastern/Arabic Male∗ (2010) (1)
- Running title : Goal-inhibiting statin intolerance (2016) (0)
- Update on the Familial Hypercholesterolemia Canada (FH Canada) Registry (2018) (0)
- PARTICIPATION BARRIERS TO CARDIAC REHABILITATION (1996) (0)
- W12-P-017 Lipoprotein(A) level is an independent predictor of age of first cardiovascular event in patients with heterozygous familial hypercholesterolemia (2005) (0)
- UvA-DARE (Digital Academic Repository) Age and residuel cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes (2016) (0)
- Molecular diagnosis of abnormalities of HDL cholesterol by targeted next-generation sequencing (2015) (0)
- Cholestyramine tablets, a new option in the treatment of hypercholesterolemia (1994) (0)
- A patient’s informative mistake: niacin is very effective in correcting dyslipidaemia (2010) (0)
- MEASUREMENT OF CIRCULATING PREGNANCY-ASSOCIATED PLASMA PROTEIN A (CPAPP-A) IDENTIFIES PATIENTS WITH ACUTE CORONARY SYNDROMES (2010) (0)
- TARGETED NEXT-GENERATION SEQUENCING TO DIAGNOSE ABNORMALITIES OF HDL CHOLESTEROL (2015) (0)
- Abstract: P820 APOLIPOPROTEIN B VERSUS LDL-CHOLESTEROL: ASSOCIATION WITH OTHER RISK FACTORS FOR ATHEROSCLEROSIS (2009) (0)
- PO14-383 IMPACT OF FAMILY HISTORY OF PREMATURE CORONARY ARTERY DISEASE ON CAROTID ULTRASOUND TRAITS AND TOTAL HOMOCYSTEINE LEVELS (2007) (0)
- Lipid metabolism in non-endocrine disease (1990) (0)
- HYPERHOMOCYST(E)INEMIA AS A RISK FACTOR FOR CORONARY ARTERY DISEASE: WHO IS AT RISK: 11 (1997) (0)
- 1.P.155 Effects of cardiac rehabilitation program on plasma lipoprotein-cholesterol levels in obese man (1997) (0)
- P41 CHARACTERIZATION OF PATIENTS WITH VERY HIGH PLASMA HDL-CHOLESTEROL, WITH AND WITHOUT VASCULAR PATHOLOGY (2010) (0)
- Insulin resistance (1996) (0)
- Thyroid Peroxidase Antibody Predicts Antenatal Complications (2000) (0)
- Targeted next-generation sequencing to diagnose disorders of HDL cholesterol patient-oriented and epidemiological research (2020) (0)
- 1.P.108 Effects of probucol on the antioxidant system in apo E-deficient mice (1997) (0)
- Can Cholesterol Ester Transfer Protein (CETP) Taq1B genotype alter the impact of standardized cardiac rehabilitation program (CRP) on lipid risk markers (2000) (0)
- Monogenic Familial Hypercholesterolemia, Polygenic Hypercholesterolemia, And The Risk Of Premature Atherosclerotic Cardiovascular Disease (2019) (0)
- W10-P-012 Relation of FER-HDL and AIP to clinical and laboratory parameters in hats (2005) (0)
- Canadian Cardiovascular Society Position Statement onFamilial Hypercholesterolemia (2014) (0)
- 2.P.63 Tolerability of phytosterols in apo E-deficient mice (1997) (0)
- REACHING TARGET LIPID LEVELS AND RESERVES IN HYPOLIPIDEMIC THERAPY IN PATIENTS AT VERY HIGH RISK OF CARDIOVASCULAR EVENTS - TWO CENTRES EXPERIENCE: PP.32.94 (2011) (0)
- Apolipoprotein-AI — An independent risk factor for atherosclerosis in low risk populations (1999) (0)
- Relative value of plasma nitrotyrosine for predicting mortality in patients with coronary artery diseases (2007) (0)
- Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: Comparison with spousal pairs without personal and family history of atherosclerosis (2000) (0)
- Clinical significance of serum HDL cholesterol. (1989) (0)
- CETP IN RARE DYSLIPIDEMIAS (2009) (0)
- Appropriate treatment of dyslipidaemia in angiographically defined British Columbians (2000) (0)
- 251 BIOMARKERS OF OXIDATIVE STRESS: RELATIVE PREDICTIVE VALUE FOR CARDIOVASCULAR MORTALITY. (2006) (0)
- Abstract 4164: Decreased Skeletal Muscle Mitochondrial DNA in Patients on High-Dose Simvastatin Therapy (2006) (0)
- Replacement of usual lipid lowering treatment by atorvastatin: Effect on plasma lipid levels (2000) (0)
- Effect of diets enriched in saturated and hydrogenated fat on HDL metabolism (2000) (0)
- 655 The association between the triglyceride-to-high-density-lipoprotein ratio and metabolic syndrome in four ethnic groups (2011) (0)
- Plasma cholesterol and red blood cell 2,3‐diphosphoglycerate (1982) (0)
- EffectofaDietaryPortfolioofCholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia A Randomized Controlled Trial (2011) (0)
- Familial combined hyperlipidemia and insulin resistance. (2001) (0)
- Modified lipoproteins and cardiovascular risk. (2001) (0)
- Oxidized low-density lipoprotein in experimental focal glomeruloscierosis (2015) (0)
- 246 Improvement in Metabolic Syndrome Component Factors Following An Intensive Lifestyle Modification Program (2012) (0)
- Extensive lifestyle management intervention following cardiac rehabilitation: Study design (2000) (0)
- W02-P-015 Novel cardiovascular risk factors in individuals with family history of premature atherosclerotic disease (2005) (0)
- Symposium - Is medical treatment of coronary artery disease superior to revasculation procedures?, Vancouver, BC, Canada, 31 May 1997 (1998) (0)
- Abstract 1095: Vascular Calcifications in Homozygote Familial Hypercholesterolemia: the Canadian Experience (2007) (0)
- Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients (2015) (0)
- Dysbetalipoproteinemia and clomipramine. Author's reply (2005) (0)
- CONTEMPORARY TRENDS IN THE MANAGEMENT AND OUTCOMES OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA (2016) (0)
- 1.P.70 Dietary supplementation with phytosterols or probucol alters fecal excretion of sterols in apo E-knockout mice (1997) (0)
- arotid Ultrasound , oronary Calcium , and yslipidemia Patterns in he MESA ( Multi-Ethnic Study f Atherosclerosis ) Cohort (0)
- Comparison of cholesterol-lowering effects of hydrogenated vs unhydrogenated tall oil phytosterols in apo E-KO mice (2000) (0)
- CAD RISK FACTORS IN HYPERALPHALIPOPROTEINEMIA (2008) (0)
- Lipoprotein-X stimulates MCP-1 expression in mesangial cells: a possible role in monocyte infiltration in familial LCAT deficiency (2000) (0)
- Abstract 6266: Targeting Metabolic Syndrome: A New Approach to Intensive Lifestyle Intervention and Self Management Support (2008) (0)
- 1.P.265 Phenotypic variation in familial hypercholesterolemia: A comparison of Chinese patients heterozygous for the same or similar mutations in the low density lipoprotein-receptor gene living in China or Canada (1997) (0)
- A Rare Disease With Diverse Manifestations (2016) (0)
- 2.P.246 Methylentetrahydrofolate reductase genotypes in young survivors of myocardial infarction (1997) (0)
- ENHANCED RELATIVE BENEFIT OF CARDIAC REHAB IN PATIENTS WITH LOW BASELINE FITNESS LEVELS. (1999) (0)
- Age and residuel cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA 1 heterozygotes (2000) (0)
- Cardiovascular risk in patients with type 2 diabetes (2005) (0)
- Cost effective diagnosis and treatment of atherosclerosis. Canadian Cardiovascular Society. (1995) (0)
- The association between triglyceride to high-density-lipoprotein ratio and insulin resistance in a multi-ethnic primary prevention cohort (2011) (0)
- Canadian Definition for Familial Hypercholesterolemia (2018) (0)
- Measurement of apolipoprotein B by radial immunodiffusion. (1983) (0)
- PO13-350 COMPARISON OF CARDIOVASCULAR RISK ASSESSMENT AND LDL CHOLESTEROL TARGET VALUES: VARIOUS GUIDELINES VERSUS CLINICAL PRACTICE (2007) (0)
- Development and Validation of a Dietary Portfolio Score for use Among Hypercholesterolemic Individuals (2015) (0)
- W12-P-035 Homocysteine and IL-6 are independent predictors of total and cardiovascular mortality in an angiography cohort (2005) (0)
- Increased Prevalence of Clinical and Sub-Clinical Atherosclerosis in Individuals With Damaging Mutations in ABCA1 and APOA1 (2017) (0)
- Reply: To PMID 25110227. (2014) (0)
- Effects of Multidisciplinary Cardiac Rehabilitation Program on Plasma Lipid Profile (1999) (0)
- 29 familial combined hyperlipoproteinemia (FCH) classified according to apolipoprotein E (APO E) phenotype (1985) (0)
- The Canadian lipid guidelines are difficult to model quantitatively. (2008) (0)
- Comprehensive care for the prevention and reduction of diabetes: a self-management focused program (2009) (0)
- Th-P15:53 Atherogenic index of plasma (AIP) is an effective predictor of cardiovascular risk (2006) (0)
- Visceral adipose tissue accumulation differs according to ethnic background : results of the Multicultural Community Health Assessment Trial ( M-CHAT ) 1 3 (2007) (0)
- Effects of combination of tall oil sterols and n-3 fatty acids on atherosclerotic lesion development in cholesterol-fed (0.2% w/w) apo E-KO mice (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jiri J. Frohlich?
Jiri J. Frohlich is affiliated with the following schools: